価格表

在庫・価格 : 2025年04月26日 12時57分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-ASyO5, Mouse-Mono <Anti-oligomer-specific anti alpha-synuclein Gly111-Tyr125>
データシート
AS13-2718 AGSアグリセラ
AgriSera AB
50 μg ¥218,000
(未発注)
追加

在庫・価格 : 2025年04月26日 12時57分 現在

Anti-ASyO5, Mouse-Mono <Anti-oligomer-specific anti alpha-synuclein Gly111-Tyr125>

  • 商品コード:AS13-2718
  • メーカー:AGS
  • 包装:50μg
  • 価格: ¥218,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Br辰nnstr旦m K et al. A generic method for design of oligomer-specific antibodies. PLoS ONE 2014;9(3):e90857
Br辰nnstr旦m K et al
2014/01/01
PubMed
2 Kilpel辰inen et al. (2019). Behavioural and dopaminergic changes in double muta...
Kilpel辰inen T et al
2019/01/01
PubMed
3 Wu et al. (2017). The critical role of Nramp1 in degrading α‐synuclein oligome...
Wu KC et al
2017/01/01
PubMed
4 Svarcbahs et al. (2016). Inhibition of Prolyl Oligopeptidase Restores Spontane...
Svarcbahs R et al
2016/01/01
PubMed
5 Limegrover CS et al. Sigma-2 receptor antagonists rescue neuronal dysfunction induced by Parkinson&#39;s patient brain-derived &#x3B1;-synuclein. J Neurosci Res 2021 04;99(4):1161-1176
Limegrover CS et al
2021/01/01
PubMed
6 Brannstrom et al. (2014). A Generic Method for Design of Oligomer-Specific Antibodies. PLoS ONE. DOI: 10.1371/journal.pone.0090857.

PubMed
7 . Reports of work goups. Compulsory continuing education as a prerequisite for relicensure. J Ala Dent Assoc 1970 Jul;54(3):50-3

1970/01/01
PubMed
8 Etel辰inen TS et al. Removal of proteinase K resistant &#x3B1;Syn species does not correlate with cell survival in a virus vector-based Parkinson&#39;s disease mouse model. Neuropharmacology 2022 Nov;218:109213
Etel辰inen TS et al
2022/01/01
PubMed
  • No.: 1
  • 文献情報:
    Br辰nnstr旦m K et al. A generic method for design of oligomer-specific antibodies. PLoS ONE 2014;9(3):e90857
    Br辰nnstr旦m K et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Kilpel辰inen et al. (2019). Behavioural and dopaminergic changes in double muta...
    Kilpel辰inen T et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Wu et al. (2017). The critical role of Nramp1 in degrading α‐synuclein oligome...
    Wu KC et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Svarcbahs et al. (2016). Inhibition of Prolyl Oligopeptidase Restores Spontane...
    Svarcbahs R et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Limegrover CS et al. Sigma-2 receptor antagonists rescue neuronal dysfunction induced by Parkinson&#39;s patient brain-derived &#x3B1;-synuclein. J Neurosci Res 2021 04;99(4):1161-1176
    Limegrover CS et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Brannstrom et al. (2014). A Generic Method for Design of Oligomer-Specific Antibodies. PLoS ONE. DOI: 10.1371/journal.pone.0090857.

  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    . Reports of work goups. Compulsory continuing education as a prerequisite for relicensure. J Ala Dent Assoc 1970 Jul;54(3):50-3

    1970/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Etel辰inen TS et al. Removal of proteinase K resistant &#x3B1;Syn species does not correlate with cell survival in a virus vector-based Parkinson&#39;s disease mouse model. Neuropharmacology 2022 Nov;218:109213
    Etel辰inen TS et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed